News Menu

CSHL launches inaugural brain tumor meeting

A glowing human brain surrounded by abstract molecular structures and digital network patterns.
CSHL鈥檚 first-ever 鈥淎dvancements in Brain Tumor Research & Therapy鈥 meeting runs from July 17 to July 20, 2025. It brings together leading researchers and clinicians to discuss the latest developments in the fight against deadly brain cancers.

Brain cancers are some of the hardest to treat. The five-year survival rate for patients with glioblastoma is only about 5% after diagnosis. Tackling this and other deadly brain cancers isn鈥檛 a one-person job; collaboration is key. What better place to get those conversations going than 黑料吃瓜资源 (CSHL)?

For more than a century, CSHL has been a hub for cutting-edge biological research and education. On July 17, 2025, the CSHL added another first to an already impressive list with its inaugural meeting on 鈥.鈥 The meeting brings together leading researchers and clinicians to discuss new breakthroughs and discoveries that may lead to more effective and targeted treatment strategies for these deadly cancers.

The 2024 brain tumor meeting poses for a photo on steps outside a building on a sunny day.
CSHL鈥檚 meetings and courses often influence one another. The 2024 summer course on Brain Tumors taught by Frank Furnari, David Gutmann, Sadhan Majumder, and Alea Mills was a major source of inspiration for the inaugural 鈥淎dvancements in Brain Tumor Research & Therapy鈥 meeting. Here, 2024 course participants pose for a group photo outside CSHL’s Banbury Center.

鈥淐SHL was really the perfect place to hold this inaugural meeting because of the power of the Meetings & Courses Program,鈥 CSHL Professor Alea Mills says. 鈥淲e鈥檙e able to bring people together from all over the globe to really tackle this problem of brain cancer. Whether you鈥檙e an undergraduate, a grad student, a postdoc, a Nobel laureate鈥攜ou鈥檙e meeting and interacting with such a diverse group of people. It sparks new ideas, new collaborations. It鈥檚 really fantastic.鈥

Mills organized the meeting alongside Eric Holland (Fred Hutchinson Cancer Center), Sadhan Majumder (MD Anderson Cancer Center), and Patrick Wen (Dana-Farber Cancer Institute). 鈥淚鈥檓 really honored to be working alongside such esteemed colleagues on this,鈥 Mills says. Forty-three speakers are scheduled to present their work on a variety of topics including cancer genetics, immunotherapy, and the clinical aspects of brain tumors.

Written by: Nick Wurm, Communications Specialist | [email protected] | 516-367-5940

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup